GADDI, ANTONIO VITTORINO
 Distribuzione geografica
Continente #
EU - Europa 4322
NA - Nord America 3447
AS - Asia 1025
AF - Africa 175
SA - Sud America 10
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 8994
Nazione #
US - Stati Uniti d'America 3441
GB - Regno Unito 1337
IT - Italia 1258
UA - Ucraina 501
CN - Cina 443
SE - Svezia 342
VN - Vietnam 306
DE - Germania 281
FR - Francia 249
IN - India 223
RU - Federazione Russa 166
ZA - Sudafrica 98
EE - Estonia 85
SC - Seychelles 43
TG - Togo 33
JP - Giappone 23
RO - Romania 18
GR - Grecia 17
NL - Olanda 13
CH - Svizzera 10
BE - Belgio 9
FI - Finlandia 8
PL - Polonia 8
BR - Brasile 7
TR - Turchia 7
AU - Australia 6
LB - Libano 6
EU - Europa 5
CA - Canada 4
CZ - Repubblica Ceca 4
ES - Italia 4
AT - Austria 3
IE - Irlanda 3
IR - Iran 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
HK - Hong Kong 2
KR - Corea 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 8994
Città #
Southend 1199
Fairfield 498
Jacksonville 351
Princeton 270
Wilmington 260
Woodbridge 236
Ashburn 232
Seattle 232
Dong Ket 195
Ann Arbor 189
Houston 167
Cambridge 160
Chandler 156
Padova 120
Westminster 117
Nanjing 109
Berlin 89
Milan 84
Saint Petersburg 69
Medford 59
Mahé 41
Hebei 40
Shenyang 39
Nanchang 38
Jinan 36
Rome 36
Dearborn 35
Bologna 34
Lomé 33
San Diego 29
Verona 25
Changsha 24
San Venanzo 23
Tokyo 23
Redwood City 22
Dallas 17
Norwalk 17
Tianjin 17
Beijing 16
Jiaxing 16
Kunming 16
Torino 15
Haikou 12
Kuban 12
Des Moines 10
Ningbo 10
Zhengzhou 10
Florence 9
Taizhou 9
Brussels 8
Helsinki 8
Mountain View 8
Napoli 8
Andover 7
Buffalo 7
Falls Church 7
Genova 7
Hangzhou 7
Hefei 7
San Francisco 7
Bucharest 6
Chicago 6
Grafing 6
Lausanne 6
Costa Mesa 5
Frankfurt Am Main 5
Fremont 5
Guangzhou 5
Istanbul 5
Lanzhou 5
Phoenix 5
Taiyuan 5
Bergamo 4
Canberra 4
Catania 4
Guidonia 4
Shanghai 4
Bari 3
Fuzhou 3
Leawood 3
Modena 3
Muizenberg 3
Naples 3
Pescara 3
Piazza 3
Pozzuoli 3
Provo 3
Redmond 3
San Genesio Ed Uniti 3
San Giuliano Milanese 3
San Mateo 3
São Paulo 3
Torre Del Greco 3
Villapiana 3
Arezzo 2
Auckland 2
Benevento 2
Bientina 2
Bordighera 2
Brescia 2
Totale 5684
Nome #
La fame d’amore: un bambino che sta bene non piange. 779
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 515
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 140
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. 117
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates. 111
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. 107
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. 107
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 104
Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related with the lipid oxidative damage: the EUROLIVE Study. 101
Metabolic Syndrome prevalence in Italy. 100
Effects of a new low dose soy protein β-sitosterol association on plasma lipid levels and oxidation 99
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. 99
Assessment of the health status in the Massa Lombarda cohort: a preliminary description of the program evaluating cardio-cerebro-vascular disease risk factors and quality of life in an elderly population. 99
Linkage disequilibrium patterns and tagSNP transferability among European populations. 98
null 98
null 98
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. 97
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10? 95
REVERSAL and PROVE-IT: are clinically oriented trials really better than "pure" scientific studies? 93
null 93
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 92
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. 91
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 90
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 90
Epidemiologia delle malattie cerebrovascolari. 88
Physical activity, exercise and cardiovascular health 87
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. 85
The influence of statin medications on Prostate Specific Antigen levels. 83
null 83
null 82
Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. 80
BlueC@rdio 80
Novel mutation in the ApoB Gene (Apo B-15.56): A Case Report. 80
Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept. 80
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Heart Study. 79
Metabolic Effects of Pioglitazone and Rosiglitazone in patients with diabetes and metabolic syndrome treated with Glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. 79
Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. 78
Sources of variabilità of plasma HDL-cholesterol levels. 78
Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL. 77
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al. 76
Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project 75
null 74
Complementary and alternative medicine for hypertension. What evidence is there for herbalist suggestions? 74
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor 74
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. 73
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study. 72
Proteine della Soia. Effetti metabolici e ruolo nella prevenzione cardiovascolare 72
Otoscopic examination: a diagnostic contribution for atherosclerotic disease? 72
Effect of Sulodexide on Albuminuria, NAG Excretion and Glomerular Filtration Response to Dopamine in Diabetic Patients. 72
null 71
Effect of a dietary education program on plasma lipid level in a rural setting: the Brisighella Heart Study 71
Efficacia della supplementazione dietetice con fibre solubili nelle gestione del rischio delle malattie cardiovascolari di pazienti affetti da SM: un trial clinico randomizzato open label di un anno 70
Primary variation in serum HDL-cholesterol levels: an independent cardiovascular risk factor in healthy adults? 69
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. 69
Prevalenza e determinati clinico-laboratoristici della sindrome metabolica in un campione di soggetti in età geriatrica: il Brisighella Heart Study 68
Modification of the dietary habits in the Brisighella Heart Study 68
null 68
A dietary education program involving the general population balances the effects of menopause on cardiovascular risk factors and metabolic syndrome incidence: data from the Brisghella Heart Study 68
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 68
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. 67
Physical activity and cardiovascular disease mortality: the Brisighella heart study 66
null 66
Otoscopic findings in hypercholesterolemic subjects 66
Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension. 66
Physical activity trend in a rural population submitted to a nutritional program: the Brisighella Heart Study 66
Non-pharmacological control of plasma cholesterol levels. 66
Prevalence of metabolic syndrome in working population: preliminary results fo a campaign of cardiovascular risk screening 65
Attività fisica e aterosclerosi: i dati di Brisghella 65
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial. 65
Brisghella Heart Study (BHS): ipertensione ed obesità. 64
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered. 63
Assocaition between hyperCKPemia and hypercholesterolemia in general population: casual phenotype or genic cluster? 62
Causes of statin interruption by hyperlipidaemic patients: the result of survey on 218 consecutive patients. 61
Plasma lipid effects of corn oil and extra-virgin olive oil in hypercholesterolemic subjects: a randomized, controlled trial. 60
What herbalists suggest to our diabetic patients in order to improve their glycaemic control? Evaluation of scientific evidences and potential risks. 58
Software per l'identificazione automatica delle iperlipoproteinemie genetiche 57
null 57
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial. 57
Observation of possibly relations between trend of CPK levels and LDL cholesterol in patients with hypercholesterolemia and asymptomatic primary high level of creatinechinase under statin therapy 56
Sito del core curriculum nazionale dei corsi di Laurea in Medicina e Chirurgia 56
Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. 55
Piano Regionale della Prevenzione (2005-2008; volume 44) 55
EUROLIVE 55
Confronto di due algoritmi diagnostici nella strima della prevalenza della sindrome metabolica in soggetti in età geriatrica e nella popolazione gnerale: Il Brisighella Heart Study. 55
Metabolic syndrome and prevalence of instrumental atherosclerosis or its clinical complications in 1000 subjects affected by different forms of familial hyperlipoproteinemia. 54
Treatment of peripheral obstructive artery disease: a battle that could be winned also with drugs? [Trattamento dell'arteriopatia obliterante degli arti inferiori: Una battaglia che può essere vinta anche con i farmaci?] 53
Osservazioni clinico sperimentali su possibili relazioni tra andamento dei valori sierici di creatinina kinasi e colesterolo LDL in pazienti asintomatici con ipercoelsterolemia ed elevati livelli di CPK in corso di terapia con statine. 52
Practical reccomendations for Familial Combined Hyperlipidemia diagnosis and management: an update. 52
Role of olive oil in the health: results form the Eurolive Study. 51
null 51
Massa Lombarda Project (Prevention and control of cardiovascular diseases: Instant Individual Definition and Bluc@ardio Project) 50
Consapevolezza, trattamento e controllo della pressione artersiosa e modificazioni temporali nell'impiego dei farmaci antiipertensivi. 49
Main predictors of metabolic syndrome and type 2 diabetes development in the historical cohort of the Brisighella Heart Study: a 16 years follow-up. 48
Obesity related health risk and social cost. 47
Strumenti diagnostici per l’identificazione delle iperlipoproteinemie a base genetica. 47
Progetto Best Practice - Ipercolesterolemia (cfr sito) 47
The relevance of soluble fibre dietary supplement in cardiovacular disease risk menagement of patients affected by metabolic syndrome (MS): a 1-year, open label, randomized clinical trial. 46
Criteri di appropriatezza clinica, tecnologica e strumentale nell'assistenza alle malattie del sistema cardiovascolare 45
Incontro sull'eccellenza didattica tra Dodenti della Facoltà di Medicina del Karolinska Institute e dell'Università di Bologna 45
Regression of atherosclerosis after one year of treatment with low dosed rosuvastatin: the role of patient selection. 45
Totale 8467
Categoria #
all - tutte 10761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018276 0000 00 00 002679
2018/20191082 5310513178 34113 6438 11617163134
2019/20202805 5238480204 228274 311383 29319676153
2020/20212092 37414778132 69154 82141 175148157435
2021/20222152 19888134134 210145 50152 87119456379
2022/2023750 3033201270 00 00 0000
Totale 9194